Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
106M
-
Number of holders
-
167
-
Total 13F shares, excl. options
-
52M
-
Shares change
-
-54.3K
-
Total reported value, excl. options
-
$1.36B
-
Value change
-
-$628K
-
Put/Call ratio
-
1.08
-
Number of buys
-
94
-
Number of sells
-
-60
-
Price
-
$26.16
Significant Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q3 2022
193 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q3 2022.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 167 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52M shares
of 106M outstanding shares and own 49.2% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.93M shares), VANGUARD GROUP INC (4.46M shares), STATE STREET CORP (4.14M shares), PFM Health Sciences, LP (3.38M shares), FMR LLC (3.36M shares), BVF INC/IL (2.72M shares), Octagon Capital Advisors LP (2.67M shares), Invus Financial Advisors, LLC (1.61M shares), PICTET ASSET MANAGEMENT SA (1.49M shares), and BOXER CAPITAL, LLC (1.43M shares).
This table shows the top 167 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.